Results 61 to 70 of about 377,889 (137)

Genotype Distribution Change After Human Papillomavirus Vaccination in Two Autonomous Communities in Spain

Frontiers in Cellular and Infection Microbiology, 2021
ContextIt has been more than 10 years since the human papillomavirus (HPV) vaccination program was initiated in most advanced countries. Thus, it seems necessary to change the uterine cervical cancer screening strategy.
Javier Freire-Salinas, Rafael Benito, Ainara Azueta, Joaquina Gil, Claudia Mendoza, Montserrat Nicolás, Pilar García-Berbel, Sonia Algarate, Javier Gómez-Román   +8 more
doaj   +1 more source

Cervical cancer screening adherence following initial HIV testing in Eswatini

HIV Medicine, Volume 27, Issue 6, Page 1008-1017, June 2026.
Abstract Objective Adherence to cervical cancer screening reduces cervical cancer mortality, particularly in settings with high HIV prevalence. We conducted the first nationwide study examining adherence to cervical cancer screening following first HIV testing in Eswatini, a country with the highest HIV prevalence globally.
Mpumelelo G. Ndlela, Lerato N. Vilakati, Victor Williams, Ntombifuthi M. Ginindza, Nomalanga P. Hlophe, Jason J. Liu   +5 more
wiley   +1 more source

Biopharmaceuticals for Cancer Treatment: An Update

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Anupom Deb Nath, Yousuf Alam, Afsana Mustak Mim, Maksuda Akter, Mohammad Abbas Gani, Khondaker Muhammad Khairul Alam, Md. Nur Alam   +6 more
wiley   +1 more source

ç©æ¥­ç®¡çå¬å¸æåå®å¹æ¨¡å¼ä¹å»ºç« [PDF]

, 2014
æåä¹ç©æ¥­ç®¡ç(Property Management, PM)å¬å¸ä¹ç¢åï¼ç©ç®¡æåçå質èå¹æ ¼çºå½±é¿ç©ç®¡å¬å¸ç¶ç績æä¹ééµã檢è¦ç¾ä»ç©æ¥­ç®¡çç¢æ¥­ä¹æ¦æ³ï¼ç±æ¼åå°åå§æ³ä»¤ä¸å¥å¨åé²å¥é檻è¼ä½ä¹å½±é¿ï¼ä»¥è³æ¼ç©æ¥­ç®¡ç業èèæ¼åå競ç­çç°å¢ï¼é²èé æ業èé競ç­åå¹å½±é¿å¶å質èå©æ½¤ãçºæ­¤ï¼åå ...
è¡æä¿®
core  

Systemic Bevacizumab Therapy in Recurrent Respiratory Papillomatosis: First Preliminary Study From Azerbaijan

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 2, April 2026.
ABSTRACT Objective To report the first clinical experience from Azerbaijan using systemic bevacizumab therapy for the treatment of recurrent respiratory papillomatosis (RRP) and to evaluate its efficacy in reducing recurrence and surgical burden in both pediatric and adult patients.
Ramil Hashimli, Aynur Aliyeva
wiley   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, Volume 48, Issue 2, Page 259-271, April 2026.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Human papillomavirus and cervical cancer: Gardasil^® vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students [PDF]

, 2010
Human papillomavirus and cervical cancer: Gardasil® vaccination status and knowledge amongst a nationally representative sample of Australian secondary school ...
MK Pitts (14446140), Paul Agius (14681992), AMA Smith (14446134), A Mitchell (7674848)   +3 more
core  

Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.

PLoS ONE, 2020
BACKGROUND:Cervical cancer associated with high risk-human papillomavirus (HR-HPV) infection is becoming the one of the most common female cancer in many sub-Saharan African countries. First-generation immigrant African women living in Europe are at-risk
Ralph-Sydney Mboumba Bouassa, Hélène Péré, Camélia Gubavu, Thierry Prazuck, Mohammad-Ali Jenabian, David Veyer, Jean-François Meye, Antoine Touzé, Laurent Bélec   +8 more
doaj   +1 more source

High‐Risk HPV in Men: A Hidden Threat to Public Health?

Reviews in Medical Virology, Volume 36, Issue 2, March 2026.
ABSTRACT High‐risk human papillomavirus (HR‐HPV) infection is a leading cause of several cancers, including those of the genital and oropharyngeal regions. While public health efforts have largely focused on women due to its link to cervical cancer, HPV also poses significant risks to men, particularly in the oropharyngeal regions. HR‐HPV prevalence in
Keesha L. Coker, Ethan L. Morgan
wiley   +1 more source

Computational modeling of the immune responses induced by both natural HPV infections and vaccination with Gardasil® [PDF]

, 2011
L’infection au papillomavirus humain (HPV) est connue pour être le principal facteur causal d’une série de maladies aussi bien bénignes (condylomatose ano-génitale, papillomatose lyringée, et autres) que malignes (cancer du col de l’utérus, certains ...
Olivera-Botello, Gustavo
core